Cite
Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study
MLA
Hui Xin Ong, et al. “Combination of Urea-Crosslinked Hyaluronic Acid and Sodium Ascorbyl Phosphate for the Treatment of Inflammatory Lung Diseases: An in Vitro Study.” European Journal of Pharmaceutical Sciences, vol. 120, July 2018, pp. 96–106. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46e020d7814d4807fea8e91c15665b60&authtype=sso&custid=ns315887.
APA
Hui Xin Ong, Daniela Traini, Paul M. Young, Laura Busato, Arianna Fallacara, Michele Pozzoli, Maliheh Ghadiri, & Stefano Manfredini. (2018). Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study. European Journal of Pharmaceutical Sciences, 120, 96–106.
Chicago
Hui Xin Ong, Daniela Traini, Paul M. Young, Laura Busato, Arianna Fallacara, Michele Pozzoli, Maliheh Ghadiri, and Stefano Manfredini. 2018. “Combination of Urea-Crosslinked Hyaluronic Acid and Sodium Ascorbyl Phosphate for the Treatment of Inflammatory Lung Diseases: An in Vitro Study.” European Journal of Pharmaceutical Sciences 120 (July): 96–106. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....46e020d7814d4807fea8e91c15665b60&authtype=sso&custid=ns315887.